Kimberly-Clark to Acquire Kenvue
Kimberly-Clark announced it will acquire Kenvue in a cash and stock transaction valued at $48.7 billion.
The deal combines two iconic companies with complementary products, including 10 billion-dollar brands, touching nearly half the global population.
- Combined company: $32 billion annual net revenues (2025 projection)
- Adjusted EBITDA: approximately $7 billion (2025 projection)
Kenvue, a Johnson & Johnson spinoff, is the world’s largest pure-play consumer health company, with brands like:
- Aveeno
- BAND-AID Brand
- Johnson’s
- Listerine
- Neutrogena
- Tylenol
Kimberly-Clark’s brands include Huggies, Kleenex, and others, holding No. 2 share positions in approximately 70 countries.
No additional quote available
Author summary: Kimberly-Clark acquires Kenvue for $48.7 billion.